Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-Hypertensive Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-Hypertensive Drugsmarket, defines the market attractiveness level of Anti-Hypertensive Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-Hypertensive Drugs industry, describes the types of Anti-Hypertensive Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-Hypertensive Drugs market and the development prospects and opportunities of Anti-Hypertensive Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-Hypertensive Drugs market in Chapter 13.
By Player:
Sanofi
Ranbaxy Laboratories
Novartis
AstraZeneca
Takeda Pharmaceutical
Merck
Johnson & Johnson
Pfizer
Lupin
Daiichi Sankyo Company Limited
By Type:
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-Hypertensive Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-Hypertensive Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-Hypertensive Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-Hypertensive Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-Hypertensive Drugs Market Analysis and Outlook to 2022
-
7.1 Global Anti-Hypertensive Drugs Consumption (2017-2022)
-
7.2 United States Anti-Hypertensive Drugs Consumption (2017-2022)
-
7.3 Europe Anti-Hypertensive Drugs Consumption (2017-2022)
-
7.4 China Anti-Hypertensive Drugs Consumption (2017-2022)
-
7.5 Japan Anti-Hypertensive Drugs Consumption (2017-2022)
-
7.6 India Anti-Hypertensive Drugs Consumption (2017-2022)
-
7.7 South Korea Anti-Hypertensive Drugs Consumption (2017-2022)
8 Region and Country-wise Anti-Hypertensive Drugs Market Analysis and Outlook to 2028
-
8.1 Global Anti-Hypertensive Drugs Consumption Forecast (2022-2028)
-
8.2 United States Anti-Hypertensive Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Anti-Hypertensive Drugs Consumption Forecast (2022-2028)
-
8.4 China Anti-Hypertensive Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Anti-Hypertensive Drugs Consumption Forecast (2022-2028)
-
8.6 India Anti-Hypertensive Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-Hypertensive Drugs Consumption Forecast (2022-2028)
9 Global Anti-Hypertensive Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-Hypertensive Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Diuretics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Beta Blockers Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Alpha Blockers Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Vasodilators Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-Hypertensive Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Anti-Hypertensive Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-Hypertensive Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Diuretics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Alpha Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-Hypertensive Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-Hypertensive Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-Hypertensive Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-Hypertensive Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-Hypertensive Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-Hypertensive Drugs Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Anti-Hypertensive Drugs Product and Service
-
14.2 Ranbaxy Laboratories
-
14.2.1 Ranbaxy Laboratories Company Details
-
14.2.2 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Anti-Hypertensive Drugs Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Anti-Hypertensive Drugs Product and Service
-
14.5 Takeda Pharmaceutical
-
14.5.1 Takeda Pharmaceutical Company Details
-
14.5.2 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Anti-Hypertensive Drugs Product and Service
-
14.7 Johnson & Johnson
-
14.7.1 Johnson & Johnson Company Details
-
14.7.2 Johnson & Johnson Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Johnson & Johnson Anti-Hypertensive Drugs Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Anti-Hypertensive Drugs Product and Service
-
14.9 Lupin
-
14.9.1 Lupin Company Details
-
14.9.2 Lupin Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Lupin Anti-Hypertensive Drugs Product and Service
-
14.10 Daiichi Sankyo Company Limited
-
14.10.1 Daiichi Sankyo Company Limited Company Details
-
14.10.2 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-Hypertensive Drugs
-
Figure Anti-Hypertensive Drugs Picture
-
Table Global Anti-Hypertensive Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Hypertensive Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Hypertensive Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-Hypertensive Drugs Consumption by Country (2017-2022)
-
Figure United States Anti-Hypertensive Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-Hypertensive Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Anti-Hypertensive Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-Hypertensive Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Anti-Hypertensive Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-Hypertensive Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Hypertensive Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-Hypertensive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-Hypertensive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-Hypertensive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-Hypertensive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-Hypertensive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-Hypertensive Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diuretics Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
Figure Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Beta Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Alpha Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Diuretics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alpha Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-Hypertensive Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-Hypertensive Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Anti-Hypertensive Drugs Product and Service
-
Table Ranbaxy Laboratories (Foundation Year, Company Profile and etc.)
-
Table Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ranbaxy Laboratories Anti-Hypertensive Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Anti-Hypertensive Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Anti-Hypertensive Drugs Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Anti-Hypertensive Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Anti-Hypertensive Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Anti-Hypertensive Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Anti-Hypertensive Drugs Product and Service
-
Table Lupin (Foundation Year, Company Profile and etc.)
-
Table Lupin Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Anti-Hypertensive Drugs Product and Service
-
Table Daiichi Sankyo Company Limited (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product and Service
-
